Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators - Poll - MDSpire

Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators

  • By

  • Kinga K. Tomczak

  • Jason P. Swindle

  • Firas M. Dabbous

  • Donald L. Gilbert

  • George B. Karkanias

  • Sarah D. Atkinson

  • Frederick E. Munschauer

  • Faizan Mazhar

  • Charlotte A. Pettersson

  • Stephen P. Wanaski

  • Timothy M. Cunniff

  • David A. Isaacs

  • June 2, 2026

  • 0 min

Share

Original Source(s)

Treatment non-persistence in children and adolescents with Tourette syndrome newly treated with dopamine D2 receptor modulators

  • by Kinga K. Tomczak, Jason P. Swindle, Firas M. Dabbous, Donald L. Gilbert, George B. Karkanias, Sarah D. Atkinson, Frederick E. Munschauer, Faizan Mazhar, Charlotte A. Pettersson, Stephen P. Wanaski, Timothy M. Cunniff, David A. Isaacs

  • June 2, 2026

Related Content

Reduced left dorsolateral prefrontal activation and right inferior frontal de-oxygenation differ between psychotic and non−psychotic adolescent depression during verbal fluency

Microstructural abnormalities in the ATR and VOF underlie tone awareness deficits in Chinese children with developmental dyslexia: a DTI study

Human neural organoid modeling of diffuse midline glioma captures the complexity of patient tumors